Virtus is the biggest IVF operator in the country, running IVF Australia, Melbourne IVF, Queensland Fertility Group and The Fertility Centre. Virtus raised $350 million last June, and the shares issued at $5.68 have since jumped by 43%. In February Virtus reported half-yearly revenues of $101 million, up 8%, and a 10% rise in net profit to $17 million.
Maybe baby: IVF company profits up, but can they last?
The IVF industry is booming, with profits up and share prices rising. But are the private companies performing the procedure accountable to their clients or their shareholders? Can they do both? And does it matter?